Since the discovery of hepatitis B virus (HBV) over five decades ago, there have been many
independent studies showing presence of HBV genomes in cells of the immune system …

Chronic Hepatitis B Virus (HBV) infection poses a significant global health burden. Although,
effective treatment and vaccinations against HBV are available, challenges still exist …

Abstract Porcine circovirus 2 (PCV2) is a single stranded DNA virus with one of the highest
mutation rates among DNA viruses. This ability allows it to generate a cloud of mutants …

Chronic viral hepatitis infections are a major public health concern, with an estimated 290
million individuals infected with hepatitis B virus (HBV) globally. This virus has been a …

Hepatitis B virus (HBV) infection results in different clinical presentation due to different
levels of immune response. Our study aimed to characterize HBV full-length genome …

Chronic infection with Hepatitis B virus (HBV) is a major risk factor for the development of
advanced liver disease including fibrosis, cirrhosis, and hepatocellular carcinoma (HCC) …

Background In sub-Saharan Africa, the hepatitis B virus (HBV) and human
immunodeficiency virus (HIV) infections are endemic. Although there has been great …

Immune-escape hepatitis B virus (HBV) mutants play an important role in HBV spread.
Recently, the multivalent vaccine Bubo®-Unigep has been developed to protect against …

The hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma (HCC), partly
driven by viral integration and specific oncogenic HBV variants. However, the biological …

Currently, the only effective therapy for cirrhosis of the liver is liver transplantation. However,
finding a compatible liver is difficult due to the low supply of healthy livers and the ever …